Tyra Biosciences, Inc.TYRANASDAQ

Revenue (LTM)

Net Income (LTM)

$-120M

-38.7% YoY

Free Cash Flow

$-95M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.1B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	0	0	0	0	0
Gross Profit	0	0	0	0	-1
Operating Income	-26	-59↓124.2%	-80↓35.7%	-104↓30.3%	-133↓27.4%
Net Income	-26	-55↓110.4%	-69↓25.0%	-86↓25.1%	-120↓38.7%
EBITDA	-26	-59↓124.2%	-80↓35.7%	-104↓30.2%	-119↓15.2%
EPS Diluted	-0.63	-1.23↓95.2%	-1.62↓31.7%	-1.51↑6.8%	-2.01↓33.1%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	302	251↓16.9%	58↓76.9%	92↑58.5%	77↓15.9%
Total Current Assets	304	257↓15.4%	212↓17.7%	347↑64.2%	265↓23.6%
Total Assets	307	266↓13.2%	226↓15.1%	364↑61.0%	283↓22.3%
Total Current Liabilities	4	6↑57.7%	15↑169.0%	15↓4.8%	18↑24.0%
Total Liabilities	5	8↑68.3%	22↑158.6%	20↓5.5%	23↑14.8%
Total Equity	302	258↓14.6%	204↓20.8%	343↑68.0%	259↓24.5%
Total Debt	1	3↑121.6%	6↑147.7%	6↓4.2%	6↓6.6%
Net Debt	-301	-249↑17.4%	-52↑79.3%	-86↓66.5%	-72↑16.5%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-24	-50↓111.8%	-50↑0.3%	-70↓39.2%	-95↓36.4%
Capital Expenditure	-1	-1↑15.4%	-1↓37.7%	-1↑13.8%	-0↑78.8%
Free Cash Flow	-24	-51↓108.3%	-51↓0.1%	-70↓38.4%	-95↓35.3%
Stock-Based Comp	3	11↑266.7%	0	23	28↑22.8%
Net Change in Cash	287	-51↓117.8%	-193↓279.1%	34↑117.6%	-15↓142.9%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance